메뉴 건너뛰기




Volumn 21, Issue 3, 2012, Pages 321-328

The therapeutic potential of GPR119 agonists for type 2 diabetes

Author keywords

cell; GPR119; Pancreatic; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; APD 597; AR 231453; AS 1269574; AS 1535907; AS 1907417; CYCLIC AMP; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR 199 AGONIST; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; GSK 1292263; INCRETIN; MBX 2982; PSN 821; UNCLASSIFIED DRUG;

EID: 84856918822     PISSN: 13543784     EISSN: 17447658     Source Type: Journal    
DOI: 10.1517/13543784.2012.657797     Document Type: Review
Times cited : (82)

References (71)
  • 1
    • 0032560807 scopus 로고    scopus 로고
    • Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
    • DOI 10.1056/NEJM199807233390404
    • Haffner SM, Lehto S, Ronnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34 (Pubitemid 28350165)
    • (1998) New England Journal of Medicine , vol.339 , Issue.4 , pp. 229-234
    • Haffner, S.M.1    Lehto, S.2    Ronnemaa, T.3    Pyorala, K.4    Laakso, M.5
  • 2
    • 0026469096 scopus 로고
    • Diabetic retinopathy A clinical overview
    • Davis MD. Diabetic retinopathy. A clinical overview. Diabetes Care 1992;15:1844-74
    • (1992) Diabetes Care , vol.15 , pp. 1844-1874
    • Davis, M.D.1
  • 3
    • 0033533807 scopus 로고    scopus 로고
    • Nephropathy in patients with type 2 diabetes mellitus
    • DOI 10.1056/NEJM199910073411506
    • Ritz E, Orth SR. Nephropathy in patients with type 2 diabetes mellitus. N Engl J Med 1999;341:1127-33 (Pubitemid 29466226)
    • (1999) New England Journal of Medicine , vol.341 , Issue.15 , pp. 1127-1133
    • Ritz, E.1    Orth, S.R.2
  • 5
    • 0028229508 scopus 로고
    • Insulin resistance or insulin deficiency Which is the primary cause of NIDDM?
    • Taylor SI, Accili D, Imai Y. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 1994;43(6):735-40
    • (1994) Diabetes , vol.43 , Issue.6 , pp. 735-740
    • Taylor, S.I.1    Accili, D.2    Imai, Y.3
  • 6
    • 9444242665 scopus 로고    scopus 로고
    • Five of stages of evolving β-cell dysfunction during progression to diabetes
    • DOI 10.2337/diabetes.53.suppl-3.S16
    • Weir GC, Bonner-Weir S. Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 2004;53:S16-21 (Pubitemid 39564517)
    • (2004) Diabetes , vol.53 , Issue.SUPPL. 3
    • Weir, G.C.1    Bonner-Weir, S.2
  • 7
    • 34247362354 scopus 로고    scopus 로고
    • Pancreatic islet dysfunction in type 2 diabetes: A rational target for incretin-based therapies
    • DOI 10.1185/030079906X167336
    • Meece J. Pancreatic islet dysfunction in type 2 diabetes: a rational target for incretin-based therapies. Curr Med Res Opin 2007;23(4):933-44 (Pubitemid 46631496)
    • (2007) Current Medical Research and Opinion , vol.23 , Issue.4 , pp. 933-944
    • Meece, J.1
  • 9
    • 79960164790 scopus 로고    scopus 로고
    • Diabetes drug may be associated with increase in risk of bladder cancer
    • Stephenson J. Diabetes drug may be associated with increase in risk of bladder cancer. JAMA 2011;306(2):143
    • (2011) JAMA , vol.306 , Issue.2 , pp. 143
    • Stephenson, J.1
  • 10
    • 84856896615 scopus 로고    scopus 로고
    • Briefing document: July 13-14 FDA. Washington, DC [Last accessed 1 November 2011]
    • Briefing document: July 13-14, 2010 meeting of the Endocrinologic and Metabolic Drugs Advisory Committee. FDA. Washington, DC, 2010. Available from: www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/ EndocrinologicandMetabolicDrugs AdvisoryCommittee/ucm191113.htm [Last accessed 1 November 2011]
    • (2010) 2010 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee
  • 11
    • 64749100501 scopus 로고    scopus 로고
    • Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
    • Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32(1):193-203
    • (2009) Diabetes Care , vol.32 , Issue.1 , pp. 193-203
    • Nathan, D.M.1    Buse, J.B.2    Davidson, M.B.3
  • 12
    • 34248223285 scopus 로고    scopus 로고
    • Biology of Incretins: GLP-1 and GIP
    • DOI 10.1053/j.gastro.2007.03.054, PII S001650850700580X
    • Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007;132:2131-57 (Pubitemid 46711096)
    • (2007) Gastroenterology , vol.132 , Issue.6 , pp. 2131-2157
    • Baggio, L.L.1    Drucker, D.J.2
  • 13
    • 0035405821 scopus 로고    scopus 로고
    • Glucagon-Like Peptide-1 and Exendin-4 Stimulate β-Cell Neogenesis in Streptozotocin-Treated Newborn Rats Resulting in Persistently Improved Glucose Homeostasis at Adult Age
    • Tourrel C, Bailbe D, Meile MJ, et al. Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes 2001;50(7):1562-70 (Pubitemid 33639596)
    • (2001) Diabetes , vol.50 , Issue.7 , pp. 1562-1570
    • Tourrel, C.1    Bailbe, D.2    Meile, M.-J.3    Kergoat, M.4    Portha, B.5
  • 14
    • 77956581914 scopus 로고    scopus 로고
    • Incretin agents in type 2 diabetes
    • Ross SA, Ekoe JM. Incretin agents in type 2 diabetes. Can Fam Physician 2010;56(7):639-48
    • (2010) Can Fam Physician , vol.56 , Issue.7 , pp. 639-648
    • Ross, S.A.1    Ekoe, J.M.2
  • 15
    • 0242710648 scopus 로고    scopus 로고
    • Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives
    • DOI 10.1016/S0014-5793(03)01196-7
    • Fredriksson R, Hoglund PJ, Gloriam DEI, et al. Seven evolutionarily conserved human rhodopsin G protein-coupled receptors lacking close relatives. FEBS Lett 2003;554:381-8 (Pubitemid 37412518)
    • (2003) FEBS Letters , vol.554 , Issue.3 , pp. 381-388
    • Fredriksson, R.1    Hoglund, P.J.2    Gloriam, D.E.I.3    Lagerstrom, M.C.4    Schioth, H.B.5
  • 20
    • 0037024360 scopus 로고    scopus 로고
    • Identification of G protein-coupled receptor genes from the human genome sequence
    • DOI 10.1016/S0014-5793(02)02775-8, PII S0014579302027758
    • Takeda S, Kadowaki S, Haga T, et al. Identification of G protein-coupled receptor genes from the human genome sequence. FEBS Lett 2002;520:97-101 (Pubitemid 34607281)
    • (2002) FEBS Letters , vol.520 , Issue.1-3 , pp. 97-101
    • Takeda, S.1    Kadowaki, S.2    Haga, T.3    Takaesu, H.4    Mitaku, S.5
  • 21
    • 1842854529 scopus 로고    scopus 로고
    • G-protein-coupled receptors: New approaches to maximise the impact of GPCRs in drug discovery
    • DOI 10.1517/14728222.8.2.165
    • Davey J. G-protein-coupled receptors: new approaches to maximise the impact of GPCRs in drug discovery. Expert Opin Ther Targets 2004;8:165-70 (Pubitemid 38489541)
    • (2004) Expert Opinion on Therapeutic Targets , vol.8 , Issue.2 , pp. 165-170
    • Davey, J.1
  • 24
    • 33644627958 scopus 로고    scopus 로고
    • Deorphanization of a G-protein coupled receptor for oleoylethanolamide and its use in the discovery of small molecule hypophagic agents
    • Overton HA, Babbs AJ, Doel SM, et al. Deorphanization of a G-protein coupled receptor for oleoylethanolamide and its use in the discovery of small molecule hypophagic agents. Cell Metab 2006;3:167-75
    • (2006) Cell Metab , vol.3 , pp. 167-175
    • Overton, H.A.1    Babbs, A.J.2    Doel, S.M.3
  • 25
    • 33750520737 scopus 로고    scopus 로고
    • Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: Predominant localization in pancreatic polypeptide-secreting PP-cells
    • DOI 10.1016/j.bbrc.2006.10.076, PII S0006291X06023047
    • Sakamoto Y, Inoue H, Kawakami S, et al. Expression and distribution of Gpr119 in the pancreatic islets of mice and rats: predominant localization in pancreatic polypeptide-secreting PP cells. Biochem Biophys Res Commun 2006;351:474-80 (Pubitemid 44666712)
    • (2006) Biochemical and Biophysical Research Communications , vol.351 , Issue.2 , pp. 474-480
    • Sakamoto, Y.1    Inoue, H.2    Kawakami, S.3    Miyawaki, K.4    Miyamoto, T.5    Mizuta, K.6    Itakura, M.7
  • 28
    • 35748974582 scopus 로고    scopus 로고
    • Discovery of novel, orally active, synthetic GPR119 agonists as potential agents for treatment of obesity and associated metabolic disorders
    • Fyfe M, Overton H, White J, et al. Discovery of novel, orally active, synthetic GPR119 agonists as potential agents for treatment of obesity and associated metabolic disorders. Diabetes 2006;55(Suppl 1):346
    • (2006) Diabetes , vol.55 , Issue.SUPPL. 1 , pp. 346
    • Fyfe, M.1    Overton, H.2    White, J.3
  • 29
    • 35748950766 scopus 로고    scopus 로고
    • GPR119 agonists are potential novel oral agents for the treatment of diabesity
    • Fyfe M, White J, Widdowson P, et al. GPR119 agonists are potential novel oral agents for the treatment of diabesity. Diabetes 2007;56(Suppl 1):532
    • (2007) Diabetes , vol.56 , Issue.SUPPL. 1 , pp. 532
    • Fyfe, M.1    White, J.2    Widdowson, P.3
  • 30
    • 0028575660 scopus 로고
    • Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enterondocrine cell line
    • Drucker DJ, Jin T, Asa SL, et al. Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enterondocrine cell line. Mol Endocrinol 1994;8:1646-55
    • (1994) Mol Endocrinol , vol.8 , pp. 1646-1655
    • Drucker, D.J.1    Jin, T.2    Asa, S.L.3
  • 31
    • 42449126696 scopus 로고    scopus 로고
    • A role for intestinal endocrine cell-expressed GPR119 in glycemic control by enhancing GLP-1 and GIP release
    • Chu Z, Carroll C, Alfonso J, et al. A role for intestinal endocrine cell-expressed GPR119 in glycemic control by enhancing GLP-1 and GIP release. Endocrinology 2008;149:2038-47
    • (2008) Endocrinology , vol.149 , pp. 2038-2047
    • Chu, Z.1    Carroll, C.2    Alfonso, J.3
  • 32
    • 56749170734 scopus 로고    scopus 로고
    • Endogenous and synthetic agonists of GPR119 differ in signaling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells
    • Ning Y, O'Neill K, Lan H, et al. Endogenous and synthetic agonists of GPR119 differ in signaling pathways and their effects on insulin secretion in MIN6c4 insulinoma cells. Br J Pharmacol 2008;155:1056-65
    • (2008) Br J Pharmacol , vol.155 , pp. 1056-1065
    • Ning, Y.1    O'Neill, K.2    Lan, H.3
  • 33
    • 77956936188 scopus 로고    scopus 로고
    • Identification of a novel GPR119 agonist AS1269574 with in vitro and in vivo glucose-stimulated insulin secretion
    • Yoshida S, Ohishi T, Matsui T, et al. Identification of a novel GPR119 agonist, AS1269574, with in vitro and in vivo glucose-stimulated insulin secretion. Biochem Biophys Res Commun 2010;400(3):437-41
    • (2010) Biochem Biophys Res Commun , vol.400 , Issue.3 , pp. 437-441
    • Yoshida, S.1    Ohishi, T.2    Matsui, T.3
  • 34
    • 78649687741 scopus 로고    scopus 로고
    • The role of small molecule GPR119 agonist AS1535907 in glucose-stimulated insulin secretion and pancreatic beta-cell function
    • Yoshida S, Ohishi T, Matsui T, et al. The role of small molecule GPR119 agonist, AS1535907, in glucose-stimulated insulin secretion and pancreatic beta-cell function. Diabetes Obes Metab 2011;13(1):34-41
    • (2011) Diabetes Obes Metab , vol.13 , Issue.1 , pp. 34-41
    • Yoshida, S.1    Ohishi, T.2    Matsui, T.3
  • 35
    • 78149470681 scopus 로고    scopus 로고
    • Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice
    • Yoshida S, Ohishi T, Matsui T, et al. Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice. Biochem Biophys Res Commun 2010;402(2):280-5
    • (2010) Biochem Biophys Res Commun , vol.402 , Issue.2 , pp. 280-285
    • Yoshida, S.1    Ohishi, T.2    Matsui, T.3
  • 36
    • 3142728651 scopus 로고    scopus 로고
    • The role of sulphonylureas in the management of type 2 diabetes mellitus
    • DOI 10.2165/00003495-200464120-00006
    • Rendell M. The role of sulphonylureas in the management of type 2 diabetes mellitus. Drugs 2004;64(12):1339-58 (Pubitemid 38916346)
    • (2004) Drugs , vol.64 , Issue.12 , pp. 1339-1358
    • Rendell, M.1
  • 39
    • 77957274682 scopus 로고    scopus 로고
    • AS1907417 a novel GPR119 agonist as an insulinotropic and beta-cell preservative agent for the treatment of type 2 diabetes
    • Yoshida S, Tanaka H, Oshima H, et al. AS1907417, a novel GPR119 agonist, as an insulinotropic and beta-cell preservative agent for the treatment of type 2 diabetes. Biochem Biophys Res Commun 2010;400(4):745-51
    • (2010) Biochem Biophys Res Commun , vol.400 , Issue.4 , pp. 745-751
    • Yoshida, S.1    Tanaka, H.2    Oshima, H.3
  • 40
    • 0037428479 scopus 로고    scopus 로고
    • Transcription factor occupancy of the insulin gene in vivo: Evidence for direct regulation by Nkx2.2
    • DOI 10.1074/jbc.M205905200
    • Cissell MA, Zhao L, Sussel L, et al. Transcription factor occupancy of the insulin gene in vivo. Evidence for direct regulation by Nkx 2.2. J Biol Chem 2003;278:751-6 (Pubitemid 36790746)
    • (2003) Journal of Biological Chemistry , vol.278 , Issue.2 , pp. 751-756
    • Cissell, M.A.1    Zhao, L.2    Sussel, L.3    Henderson, E.4    Stein, R.5
  • 41
    • 14244266611 scopus 로고    scopus 로고
    • Minireview: Transcriptional regulation in pancreatic development
    • DOI 10.1210/en.2004-1576
    • Habener JF, Kemp DM, Thomas MK. Minireview: transcriptional regulation in pancreatic development. Endocrinology 2005;146(3):1025-34 (Pubitemid 40289291)
    • (2005) Endocrinology , vol.146 , Issue.3 , pp. 1025-1034
    • Habener, J.F.1    Kemp, D.M.2    Thomas, M.K.3
  • 42
    • 78649522751 scopus 로고    scopus 로고
    • NKX6.1 promotes PDX-1-induced liver to pancreatic beta-cells reprogramming
    • Gefen-Halevi S, Rachmut IH, Molakandov K, et al. NKX6.1 promotes PDX-1-induced liver to pancreatic beta-cells reprogramming. Cell Reprogram 2010;12(6):655-64
    • (2010) Cell Reprogram , vol.12 , Issue.6 , pp. 655-664
    • Gefen-Halevi, S.1    Rachmut, I.H.2    Molakandov, K.3
  • 43
    • 0031105975 scopus 로고    scopus 로고
    • Isolation, characterization, and chromosomal mapping of the human Nkx6.1 gene (NKX6A), a new pancreatic islet homeobox gene
    • DOI 10.1006/geno.1996.4568
    • Inoue H, Rudnick A, German MS, et al. Isolation, characterization, and chromosomal mapping of the human Nkx6.1 gene (NKX6A), a new pancreatic islet homeobox gene. Genomics 1997;40(2):367-70 (Pubitemid 27124103)
    • (1997) Genomics , vol.40 , Issue.2 , pp. 367-370
    • Inoue, H.1    Rudnick, A.2    German, M.S.3    Veile, R.4    Donis-Keller, H.5    Permutt, M.A.6
  • 44
    • 0034522773 scopus 로고    scopus 로고
    • Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats
    • DOI 10.1210/en.141.12.4600
    • Perfetti R, Zhou J, Doyle ME, et al. Glucagon-like peptide-1 induces cell proliferation and pancreatic-duodenum homeobox-1 expression and increases endocrine cell mass in the pancreas of old, glucose-intolerant rats. Endocrinology 2000;141(12):4600-5 (Pubitemid 32055138)
    • (2000) Endocrinology , vol.141 , Issue.12 , pp. 4600-4605
    • Perfetti, R.1    Zhou, J.I.E.2    Doyle, M.E.3    Egan, J.M.4
  • 45
    • 33845270456 scopus 로고    scopus 로고
    • Transcription factors regulating β-cell function
    • DOI 10.1530/eje.1.02277
    • Cerf ME. Transcription factors regulating beta-cell function. Eur J Endocrinol 2006;155:671-9 (Pubitemid 44857490)
    • (2006) European Journal of Endocrinology , vol.155 , Issue.5 , pp. 671-679
    • Cerf, M.E.1
  • 46
    • 0031985396 scopus 로고    scopus 로고
    • A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus
    • Habener JF, Stoffers DA. A newly discovered role of transcription factors involved in pancreas development and the pathogenesis of diabetes mellitus. Proc Assoc Am Physicians 1998;110(1):12-21 (Pubitemid 28051634)
    • (1998) Proceedings of the Association of American Physicians , vol.110 , Issue.1 , pp. 12-21
    • Habener, J.F.1    Stoffers, D.A.2
  • 47
    • 77950225021 scopus 로고    scopus 로고
    • Pancreatic beta cells require NeuroD to achieve and maintain functional maturity
    • Gu C, Stein GH, Pan N, et al. Pancreatic beta cells require NeuroD to achieve and maintain functional maturity. Cell Metab 2010;11(4):298-310
    • (2010) Cell Metab , vol.11 , Issue.4 , pp. 298-310
    • Gu, C.1    Stein, G.H.2    Pan, N.3
  • 48
    • 70350741391 scopus 로고    scopus 로고
    • Combination of MafA, PDX-1 and NeuroD is a useful tool to efficiently induce insulin-producing surrogate beta-cells
    • Kaneto H, Matsuoka TA, Katakami N, et al. Combination of MafA, PDX-1 and NeuroD is a useful tool to efficiently induce insulin-producing surrogate beta-cells. Curr Med Chem 2009;16(24):3144-51
    • (2009) Curr Med Chem , vol.16 , Issue.24 , pp. 3144-3151
    • Kaneto, H.1    Matsuoka, T.A.2    Katakami, N.3
  • 49
    • 0026473236 scopus 로고
    • Cellular and molecular biology of the beta cell
    • Steiner DF, James DE. Cellular and molecular biology of the beta cell. Diabetologia 1992;35(Suppl 2):S41-8
    • (1992) Diabetologia , vol.35 , Issue.SUPPL. 2
    • Steiner, D.F.1    James, D.E.2
  • 50
    • 0030065077 scopus 로고    scopus 로고
    • Specific co-ordinated regulation of PC3 and PC2 gene expression with that of preproinsulin in insulin-producing βTC3 cells
    • Schuppin GT, Rhodes CJ. Specific co-ordinated regulation of PC3 and PC2 gene expression with that of preproinsulin in insulin-producing beta TC3 cells. Biochem J 1996;313:259-68 (Pubitemid 26013453)
    • (1996) Biochemical Journal , vol.313 , Issue.1 , pp. 259-268
    • Schuppin, G.T.1    Rhodes, C.J.2
  • 52
    • 0030607672 scopus 로고    scopus 로고
    • Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor
    • DOI 10.1016/S0014-2999(96)00795-9, PII S0014299996007959
    • Knudsen LB, Pridal L. Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor. Eur J Pharmacol 1996;318(2-3):429-35 (Pubitemid 27046288)
    • (1996) European Journal of Pharmacology , vol.318 , Issue.2-3 , pp. 429-435
    • Knudsen, L.B.1    Pridal, L.2
  • 54
    • 33644627958 scopus 로고    scopus 로고
    • Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents
    • Overton HA, Babbs AJ, Doel SM, et al. Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metab 2006;3(3):167-75
    • (2006) Cell Metab , vol.3 , Issue.3 , pp. 167-175
    • Overton, H.A.1    Babbs, A.J.2    Doel, S.M.3
  • 55
    • 51849099001 scopus 로고    scopus 로고
    • Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119
    • Semple G, Fioravanti B, Pereira G, et al. Discovery of the first potent and orally efficacious agonist of the orphan G-protein coupled receptor 119 J Med Chem 2008;51(17): 5172-5
    • (2008) J Med Chem , vol.51 , Issue.17 , pp. 5172-5175
    • Semple, G.1    Fioravanti, B.2    Pereira, G.3
  • 56
    • 77950062510 scopus 로고    scopus 로고
    • 25-Disubstituted pyridines as potent GPR119 agonists
    • Wu Y, Kuntz JD, Carpenter AJ, et al. 2,5-Disubstituted pyridines as potent GPR119 agonists. Bioorg Med Chem Lett 2010;20(8):2577-81
    • (2010) Bioorg Med Chem Lett , vol.20 , Issue.8 , pp. 2577-2581
    • Wu, Y.1    Kuntz, J.D.2    Carpenter, A.J.3
  • 57
    • 79955474924 scopus 로고    scopus 로고
    • Design of potent and selective GPR119 agonists for type II diabetes
    • published online 22 December 2010 doi:10.1016/j.bmcl.2010.12.086
    • Szewczyk JW, Acton J, Adams AD, et al. Design of potent and selective GPR119 agonists for type II diabetes. Bioorg Med Chem Lett 2010;published online 22 December 2010; doi:10.1016/j.bmcl.2010.12.086
    • (2010) Bioorg Med Chem Lett
    • Szewczyk, J.W.1    Acton, J.2    Adams, A.D.3
  • 58
    • 79951726586 scopus 로고    scopus 로고
    • Design and evaluation of a 2-(2,3,6-trifluorophenyl)acetamide derivative as an agonist of the GPR119 receptor
    • Mascitti V, Stevens BD, Choi C, et al. Design and evaluation of a 2-(2,3,6-trifluorophenyl)acetamide derivative as an agonist of the GPR119 receptor. Bioorg Med Chem Lett 2011;21(5):1306-9
    • (2011) Bioorg Med Chem Lett , vol.21 , Issue.5 , pp. 1306-1309
    • Mascitti, V.1    Stevens, B.D.2    Choi, C.3
  • 60
    • 84856898231 scopus 로고    scopus 로고
    • Arena Pharmaceuticals Provides Update on GPR119 San Diego [Last accessed 1 November 2011]
    • Arena Pharmaceuticals Provides Update on GPR119 Portfolio for Type 2 Diabetes. PRNewswire. San Diego, 2010. Available from: http://invest.arenapharm. com/releasedetail.cfm?releaseid=527328 [Last accessed 1 November 2011]
    • (2010) Portfolio for Type 2 Diabetes. PRNewswire
  • 62
    • 84856824894 scopus 로고    scopus 로고
    • PRNewswire. Paris, 2011 [Last accessed 1 November 2011]
    • Sanofi-aventis: Strong Performance of Growth Platforms in Q1 2011. PRNewswire. Paris, 2011. Available from: http://www.prnewswire.com/news- releases/sanofi-aventis-strong-performance-ofgrowth-platforms-in-q1-2011- 120852319. html [Last accessed 1 November 2011]
    • (2011) Sanofi-aventis: Strong Performance of Growth Platforms in Q1
  • 63
    • 70350619609 scopus 로고    scopus 로고
    • Effects of liraglutide in the treatment of obesity: A randomised, double-blind, placebo-controlled study
    • NN8022-1807 Study Group
    • Astrup A, Rossner S, Van Gaal L, et al. NN8022-1807 Study Group. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet 2009;374:1606-16
    • (2009) Lancet , vol.374 , pp. 1606-1616
    • Astrup, A.1    Rossner, S.2    Van Gaal, L.3
  • 65
    • 77955612057 scopus 로고    scopus 로고
    • Long-term characterization of the diet-induced obese and diet-resistant rat model: A polygenetic rat model mimicking the human obesity syndrome
    • Madsen AN, Hansen G, Paulsen SJ, et al. Long-term characterization of the diet-induced obese and diet-resistant rat model: a polygenetic rat model mimicking the human obesity syndrome. J Endocrinol 2010;206:287-96
    • (2010) J Endocrinol , vol.206 , pp. 287-296
    • Madsen, A.N.1    Hansen, G.2    Paulsen, S.J.3
  • 66
    • 67649636449 scopus 로고    scopus 로고
    • Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms
    • Ruttimann EB, Arnold M, Hillebrand JJ, et al. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms. Endocrinology 2009;150:1174-81
    • (2009) Endocrinology , vol.150 , pp. 1174-1181
    • Ruttimann, E.B.1    Arnold, M.2    Hillebrand, J.J.3
  • 67
    • 76249104609 scopus 로고    scopus 로고
    • Liraglutide for weight loss in obese people
    • Thum T, Anker SD. Liraglutide for weight loss in obese people. Lancet 2010;375:551-2
    • (2010) Lancet , vol.375 , pp. 551-552
    • Thum, T.1    Anker, S.D.2
  • 70
    • 0347480400 scopus 로고    scopus 로고
    • Free fatty acids and type 2 diabetes mellitus
    • Wyne KL. Free fatty acids and type 2 diabetes mellitus. Am J Med 2003;115(Suppl 8A):29S-36S
    • (2003) Am J Med , vol.115 , Issue.SUPPL. 8A
    • Wyne, K.L.1
  • 71
    • 77749246118 scopus 로고    scopus 로고
    • Enhanced signaling downstream of ribonucleic Acid-activated protein kinase-like endoplasmic reticulum kinase potentiates lipotoxic endoplasmic reticulum stress in human islets
    • Ladriere L, Igoillo-Esteve M, Cunha DA, et al. Enhanced signaling downstream of ribonucleic Acid-activated protein kinase-like endoplasmic reticulum kinase potentiates lipotoxic endoplasmic reticulum stress in human islets. J Clin Endocrinol Metab 2010;95(3):1442-9
    • (2010) J Clin Endocrinol Metab , vol.95 , Issue.3 , pp. 1442-1449
    • Ladriere, L.1    Igoillo-Esteve, M.2    Cunha, D.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.